Protein discovery paves way for new multiple myeloma treatments
Multiple myeloma patients with the poorest prognosis are set to benefit from promising new research at Flinders University which seeks to find new treatments by targeting a protein on the surface of the cancer cells in the bone marrow.
Together with co-investigators Professors Claudine Bonder and Stuart Pitson from UniSA, Dr Wallington-Beddoe, who is also Head of Myeloma and Amyloidosis Services and Director of Haematology Clinical Trials at Flinders Medical Centre, recently discovered the presence of the DSG2 protein biomarker in some multiple myeloma patients.
He’s since found that about 20-30 per cent of newly diagnosed patients express the protein, with this group three times more likely to die within six years of diagnosis.
Dr Wallington-Beddoe and his co-investigators have been awarded a $130,000 research grant co-funded by Flinders Foundation and The Hospital Research Foundation to quickly identify newly diagnosed multiple myeloma patients who express the DSG2 protein, so they can be given the most appropriate, currently available therapies right away, whilst also searching for new treatments.
This support was made possible thanks to your generous donations to Flinders Foundation’s Multiple Myeloma appeal and from fundraisers in the community. Thank you.
Armed with this knowledge, Dr Wallington-Beddoe said the focus was now firmly on improving the prognosis for these high-risk patients by developing an antibody therapy to help manipulate the immune system to attack the cancer cells that express the protein.
“Multiple myeloma is a really hard cancer to treat at the best of times, even today it’s deemed incurable,” – Dr Wallington-Beddoe
“So, knowing about this protein and eventually having novel therapies to target it – it’s going to be a completely new playing field.”
Dr Wallington-Beddoe hopes early stage clinical trials on new therapies targeting this protein could be a reality at Flinders within five years.
“This is a big step in the right direction as the protein opens up a whole new therapeutic approach to patient specific medicine,” he says.
“And it’s such an area of need to have better therapies to treat myeloma patients that not only kill the cancer cells effectively but also minimise harmful side effects of the therapies themselves.
“My patients often ask me when we’re going to cure multiple myeloma. We’re certainly not there yet, but the approaches we are using are improving the outcomes of patients year by year.
“There’s immense hope that we can push it back more and more so that while we might not necessarily ‘beat’ it right way, we’ll push it back enough so that people can live longer and more productive lives ‘with’ it.”
You can support multiple myeloma research at Flinders by making a donation by clicking here, or phone the Flinders Foundation team on (08) 8204 5216.
This research has been co-funded by Flinders Foundation and The Hospital Research Foundation
Buying Hope” for South Australians with MND
Research and clinical trials exploring new treatments for Motor Neurone Disease (MND) will soon be underway at Flinders Medical Centre with the appointment of a new MND Fellow.
Heart care key to long term health of cancer survivors
New research out of Flinders has revealed cancer survivors require more care, awareness and management of other health conditions – in particular cardiovascular disease – to help them live longer after cancer treatment.
Virtual reality simulator for eye surgery arrives at Flinders
Trainee eye surgeons across South Australia will be able to practice delicate cataract surgery before they step into the operating theatre with the arrival of a new virtual reality simulator at Flinders Medical Centre.
Simonds Homes partners with Flinders Foundation
Simonds Homes is delighted to announce its partnership with Flinders Foundation and looks forward to working alongside their team to raise money through the sale of a new Simonds home.
Riding For My Research
When Flinders University cancer researcher Dr Ashley Hopkins jumped on his bike to join the 2019 SA Discovery Tour, he was overwhelmed by the support those riding alongside him gave to his research.
Targeted Treatments for Triple Negative Breast Cancer
Thanks to generous funding from Tour de Cure, riders and supporters in 2019, an international research project is hoping to uncover the ‘magic bullet’ for treating Triple Negative Breast Cancer – one of the most aggressive and fatal forms of breast cancer.
32 new health and medical research projects… thanks to you!
At a time when the focus on health and medical research has never been greater, 32 exciting new projects across the Flinders medical precinct have received funding in Flinders Foundation’s annual Health Seed Grant Round.
Rachel’s dream is to improve therapies to treat, and ultimately cure, multiple myeloma.
“Multiple myeloma is incurable, that’s something we’d obviously like to change.”
Promising blood test to detect head and neck cancer
Researchers at Flinders University hope their promising blood test model could help to diagnose a common form of head and neck cancer, in the same way diagnostic tests are available for other cancer types.
Heart Pillows for Heart Patients – Aboriginal and Torres Strait Islander Health –
Aboriginal and Torres Strait Islander patients undergoing heart surgery at Flinders Medical Centre (FMC) are being gifted ‘heart pillows’